LEVOVIST - PWS IV (4G GRANULES /VIAL)
LEVOVIST - PWS IV (4G GRANULES /VIAL)
Discontinued
DIN Number
02229102
Drug Class
Human
Market Date
Dec 19, 1997
Company
HC
berlex canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229102
AIG Number0228742001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V08DA02 MICROPARTICLES OF GALACTOSE
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification36:89.00*
Health Canada Classification
ACTIVE INGREDIENTS (2)
GALACTOSEActive
Strength: 999 MG / G
Monograph: GALACTOSE
PALMITIC ACIDActive
Strength: 1 MG / G
Monograph: PALMITIC ACID